临床意义
医学
生物标志物
5-羟色胺能
内科学
价值(数学)
肿瘤科
诊断生物标志物
联想(心理学)
生物信息学
临床诊断
作者
Peng Guo,Xuekang Zhan,Zhenxing Hu
标识
DOI:10.1093/jsxmed/qdag082
摘要
Premature ejaculation (PE) is a prevalent male sexual dysfunction with a complex, incompletely understood pathophysiology. The diagnosis of PE remains anchored in subjective patient reports and self-administered questionnaires. While these tools are valuable, they lack the objectivity of a measurable biological signal. This absence of a biomarker not only complicates definitive diagnosis but also impedes quantifiable tracking of treatment response. Regarding treatment, selective serotonin reuptake inhibitors (SSRIs), like dapoxetine, have established themselves as the primary pharmacological option due to their efficacy. Their therapeutic effect is broadly attributed to increasing synaptic serotonin (5-HT) levels, a neurotransmitter known to be a key regulator of ejaculatory latency.1 However, the precise mechanisms by which elevated 5-HT leads to increased ejaculatory latency, and the reasons for interindividual variability in response, remain incompletely understood. This knowledge gap points to the likely involvement of other modulating factors within the complex neurobiology of ejaculation. Our investigation turned to Nesfatin-1, a peptide originally identified for its role in appetite regulation but increasingly recognized for its broad neuroendocrine functions. Of particular interest is compelling preclinical evidence showing a close anatomical and functional interaction between Nesfatin-1 and 5-HT system in brain regions such as the dorsal raphe nucleus.2,3 Research suggests a positive feedback loop in which 5-HT receptor activation stimulates Nesfatin-1 release, while Nesfatin-1, in turn, can upregulate 5-HT synthesis. This reciprocal positive-feedback loop suggests that Nesfatin-1 may act synergistically with the 5-HT system to modulate higher-order neural circuits involved in the regulation of ejaculation. To investigate this, our study measured changes in serum levels of Nesfatin-1 and 5-HT in patients with PE before and after treatment with SSRIs and compared these levels to those in a control group. By analyzing these results, we aim to clarify the relationship between Nesfatin-1 and PE, and to explore the potential value of Nesfatin-1 in the diagnosis and treatment of PE, as well as its possible physiological mechanisms involved in ejaculatory control.
科研通智能强力驱动
Strongly Powered by AbleSci AI